0001127602-20-019788.txt : 20200616
0001127602-20-019788.hdr.sgml : 20200616
20200616175300
ACCESSION NUMBER: 0001127602-20-019788
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200612
FILED AS OF DATE: 20200616
DATE AS OF CHANGE: 20200616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scanlan Jacqueline
CENTRAL INDEX KEY: 0001713517
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 20967484
MAIL ADDRESS:
STREET 1: HAEMONETICS CORPORATION
STREET 2: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0328
BUSINESS ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-06-12
0000313143
HAEMONETICS CORP
HAE
0001713517
Scanlan Jacqueline
125 SUMMER STREET
BOSTON
MA
02110
1
SVP, Global Human Resources
Common Stock
2020-06-12
4
A
0
11286
0
A
17000
D
Common Stock
2020-06-12
4
S
0
111
89.29
D
16889
D
Common Stock
2020-06-15
4
S
0
4417
87.71
D
12472
D
Common Stock
2020-06-15
4
M
0
2889
41.64
A
15361
D
Common Stock
2020-06-15
4
S
0
4005
90.00
D
11356
D
Common Stock
2020-06-16
4
S
0
6869
91.53
D
4487
D
Non-qualified Stock Option (Right to Buy)
41.64
2020-06-15
4
M
0
2889
0
D
2020-06-06
2024-06-06
Common Stock
2889
2890
D
Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020.
This number includes unvested restricted stock units ("RSUs") previously reported.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Transaction pursuant to an existing 10b5-1 trading plan.
Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
/s/ Thomas V. Powers, attorney-in-fact for Ms. Scanlan
2020-06-16